Vietnam’s Imexpharm Loans Millions For COVID-19 Response
Financing Agreement With ABD Will Ensure Supply
Executive Summary
Vietnamese firm Imexpharm has received $8m in financing from the Asian Development Bank to help sustain local production considering the novel coronavirus pandemic.
You may also be interested in...
Sandoz Provides COVID Portfolio At Cost In Vietnam
Novartis has expanded its efforts to help low- and lower-middle-income countries “mitigate the impact of the pandemic and support healthcare systems,” after signing a memorandum of understanding with Vietnam’s Ministry of Health providing various treatments for COVID-19 at-cost.
Rani Takes Next Step As Oral Ustekinumab Biosimilar Enters The Clinic
As biosimilars to Stelara (ustekinumab) continue to advance in global markets, Rani Therapeutics has made progress for its proposed RT-111 orally administered ustekinumab biosimilar.
Alvotech’s Japanese Ustekinumab Nod Is ‘First For Global Markets’
Following the formation of their partnership nearly five years ago, Alvotech and Fuji have together welcomed approval in Japan for Alvotech’s biosimilar to Stelara (ustekinumab).